Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide.

[1]  R. Moreau,et al.  Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis. , 1989, Journal of hepatology.

[2]  R. Roman,et al.  Pressure-dependent contraction of rat juxtamedullary afferent arterioles. , 1989, Circulation research.

[3]  F. Cominelli,et al.  Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites. , 1988, Gastroenterology.

[4]  G. Daskalopoulos,et al.  Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. , 1987, Gastroenterology.

[5]  V. Arroyo,et al.  Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. , 1986, The American journal of medicine.

[6]  F. Guarner,et al.  Renal prostaglandins in cirrhosis of the liver. , 1986, Clinical science.

[7]  F. Guarner,et al.  Increased synthesis of systemic prostacyclin in cirrhotic patients. , 1986, Gastroenterology.

[8]  J. Cohn,et al.  Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. , 1985, Annals of internal medicine.

[9]  G. FitzGerald,et al.  Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.

[10]  Gerber Jg.  Role of prostaglandins in the hemodynamic and tubular effects of furosemide. , 1983 .

[11]  V. Arroyo,et al.  Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites. , 1983, Gastroenterology.

[12]  P. Halushka,et al.  Furosemide increases urine 6-keto-prostaglandin F1 alpha. Relation to natriuresis, vasodilation, and renin release. , 1982, Hypertension.

[13]  W. Powell.  Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. , 1982, Methods in enzymology.

[14]  C. Patrono,et al.  Evidence for a direct stimulatory effect of prostacyclin on renin release in man. , 1982, The Journal of clinical investigation.

[15]  J. Hoefs,et al.  Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems. , 1981, The American journal of gastroenterology.

[16]  J. Frölich,et al.  Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. , 1980, Artery.

[17]  R. Williams,et al.  Diuretic-induced renal impairment without volume depletion in cirrhosis: changes in the renin-angiotensin system and the effect of β-adrenergic blockade , 1979, Postgraduate medical journal.

[18]  J. Hoefs,et al.  Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. , 1979, The Journal of clinical endocrinology and metabolism.

[19]  E. Sellers,et al.  Adverse biochemical and clinical consequences of furosemide administration. , 1978, Canadian Medical Association journal.

[20]  V. Arroyo,et al.  Clinical types and drug therapy of renal impairment in cirrhosis , 1975, Postgraduate medical journal.

[21]  K. Kirton,et al.  Characterization of antibody to prostaglandin F 2a . , 1972, Biochemical and biophysical research communications.

[22]  A. Aho,et al.  Effect of oxygen ventilation in mesenteric arterial occlusion in the dog. , 1972, Scandinavian journal of gastroenterology.

[23]  T. Reynolds,et al.  Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis. , 1969, The Journal of clinical investigation.